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S U M M A R Y
Background: Japanese encephalitis (JE) was the leading cause of viral encephalitis among children in
South Korea in the 20th century. This study summarizes recent changes in the epidemiology of JE
following the implementation of a vigorous immunization program in the country.
Methods: Epidemiological investigations were performed for all reported laboratory-conﬁrmed JE cases,
and the cumulative incidence was calculated for the surveillance years 2007–2010.
Results: During the surveillance period, 45 cases of JE were conﬁrmed in the country, resulting in a
cumulative incidence of 0.013–0.055 cases per 100 000 population. The median age of cases was
49.4 years, and by age group, 44.4% were aged 40–49 years. Just under a quarter (22.2%) of the cases were
found to live close to a pigsty, while 42.2% of the cases were found to reside in the metropolitan areas of
Seoul, Incheon, and Gyeonggi-do. None of the cases had a history of vaccination.
Conclusions: Although JE has traditionally been regarded as a children’s disease, the majority of cases
now occur in adults in countries where strong immunization programs exist, such as in South Korea.
Consideration should be given to an adult vaccination policy in the near future.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Japanese encephalitis (JE), once an important disease in South
Korea, but which has been on the decline since the 1980s, is still a
major public health problem primarily in Asian regions.1,2
Transmitted by the vector mosquito Culex tritaeniorhynchus, JE
virus causes an illness that may be asymptomatic or that can
involve severe neurological manifestations, which may rapidly
progress to death.3 To date, there is no established treatment for
symptomatic JE, therefore control and prevention measures have
been employed, mainly vaccination and vector control strategies.3
In South Korea, JE has been reported through passive
surveillance since 1949, and vector control was the mainstay of
the public health policy before the introduction of the vaccine.4,5
The mouse brain-derived inactive vaccine, which was ﬁrst
introduced in 1971, was not widely distributed in the country
until 1983, when an outbreak resulting in 1197 cases and 40 deaths
occurred.5 This outbreak prompted the government to reorganize
the national JE control system, by enhancing surveillance with
laboratory diagnosis for every reported case, and by expanding
universal vaccination for children.6,7 As a result of these activities,* Corresponding author. Tel.: +82 43 719 7700; fax: +82 43 7197048.
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0.01 annual reported cases of JE per 100 000 population.7
Although no longer recognized as a major public health
problem in the country, sporadic cases of JE have been noted
since the beginning of the 2000s. South Korea is still considered a
potential endemic area for JE transmission, and the risk of infection
remains for residents and travelers with no vaccination history.8,9
One explanation for this persistence of the disease despite the wide
use of vaccines against JE, is that childhood vaccination confers no
herd immunity to adults or other susceptible populations because
humans are not the primary hosts.
In order to evaluate our current vaccination policy and its
impact on the prevention of JE in the country, a detailed review of
the epidemiological data of recently reported cases of JE was
necessary. To address this, the aim of the current study was to
summarize the recent epidemiological data of JE cases in South
Korea that were reported to the Korea Centers for Disease Control
and Prevention (KCDC) from 2007 to 2010.
2. Methods
JE is considered endemic in South Korea, which had an
estimated population of approximately 47 million in 2005.10
The immediate reporting of any suspected or diagnosed cases of JE
to the public health centers is mandatory for all healthcare
providers.11 This report is then forwarded to the KCDC forses. Published by Elsevier Ltd. All rights reserved.
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analyzed the data collected by the KCDC for the period January
2007 to December 2010.
2.1. Case deﬁnition
A conﬁrmed JE case is a case who has a febrile illness associated
with neurological symptoms suggestive of JE infection, which is
conﬁrmed by laboratory evidence of one or more of following: (1)
direct detection of JE virus, JE virus antigen, or JE virus gene from
brain tissue or cerebrospinal ﬂuid (CSF), (2) JE-speciﬁc IgM-capture
by ELISA on CSF or serum in the absence of IgM to other
ﬂaviviruses, and (3) a four-fold or greater rise in JE virus-speciﬁc
neutralizing antibodies between the acute and convalescent phase
serum specimens.
2.2. Epidemiological investigation
Information regarding case demographic data and potential risk
factors, such as proximity of residence to a pigsty or rice paddy,
frequent outdoor activities after 9:00 p.m. more than three times a
week, occupation involving more than 50% of the work time
outside of the building, and nationality, were collected. History of
vaccination against JE was investigated through the medical
records and the electronic immunization registry system operated
by KCDC.12 Clinical information, such as presence of underlying
diseases, admission to the intensive care unit (ICU), and death
within 3 months of symptom onset potentially associated to JE
infection, were also identiﬁed. Due to the case reporting system
being incomplete for 2007–2008, laboratory ﬁndings such as CSF
proﬁles and radiology ﬁndings (magnetic resonance imaging (MRI)
reports by licensed radiologists) were only partly identiﬁed for
2007–2008; full information was collected for 2009–2010.
2.3. Laboratory procedures
All blood and cerebrospinal ﬂuid specimens were shipped to
KCDC for testing by IgM ELISA. IgM was tested using a JE-DEM
Combo IgM ELISA (Panbio, Australia); the total titers for IgM and
IgG were measured by hemagglutinin inhibition assay or indirect
ﬂuorescent antibody test, and the ﬁnal conﬁrmation was made byTable 1
Cases of Japanese encephalitis reported to the Korea Centers for Disease Control and P
Year of surveillance 
2007 2008 
Conﬁrmed cases, n 7 6 
Cumulative incidencea 0.015 0.013 
Age group (years), n (%)
<20 0 0 
20–29 0 0 
30–39 1 (14.3) 0 
40–49 3 (42.9) 4 (66.7) 
50–59 2 (28.6) 1 (16.7) 
60 1 (14.3) 1 (16.7) 
Age (years), median (range) 50.6 (30–85) 52.3 (45–69) 
Male sex, n (%) 5 (71.4) 5 (83.3) 
Proximity to pigsty,b n (%) 0 2 (33.3) 
Proximity to rice paddy,b n (%) 2 (28.6) 0 
Outdoor activity,c n (%) 3 (42.9) 3 (50.0) 
Outdoor occupation,d n (%) 4 (57.1) 5 (83.3) 
Immigrant,e n (%) 0 2 (33.3) 
Vaccination history 1, n 0 0 
a Cumulative incidence is the number of cases per 100 000 population at risk.
b Proximity to pigsty or rice paddy was deﬁned as location of residence within 5 kil
c Outdoor activity was deﬁned as outdoor activity after 9:00 p.m. more than three t
d Outdoor occupation was deﬁned as spending more than 50% of work time outside
e Immigrant was deﬁned as a foreign-born person who had resided in Korea for moplaque reduction neutralization test. Suspected cases for whom
specimens were obtained 7 days after the onset of symptoms,
who were negative in IgM or showed low antibody titers, had a
second specimen collected 14 days after the onset of symptoms to
test for IgM and IgG. All tests were carried out at KCDC in
accordance with the manufacturer’s instructions.
2.4. Data analysis
The analysis of certain laboratory ﬁndings and MRI reports was
not done for every case, because some of the data for 2007–2008
were incomplete as a result of the less detailed case reporting form
used for suspected JE infection cases during this period. We
calculated the cumulative incidence using person-time as the
denominator, which incorporated the time period of surveillance
and the population data obtained from the Korea Statistical
Information Service (nationwide ofﬁcial statistics for the year
2005).10
3. Results
From January 2007 to December 2010, KCDC received 45
reports meeting the deﬁnition of a conﬁrmed JE case, resulting in
an annual cumulative incidence of 0.013–0.055 per 100 000
population (Table 1). The cases were reported mostly from
metropolitan areas (Seoul, Incheon, and Gyeonggi-do, n = 19),
followed by southeastern prefectures (Busan, Daegu, Ulsan,
Gyeongsangbuk-do, and Gyeongsangnam-do, n = 12), central
prefectures (Daejeon, Chungcheongbuk-do, and Chungcheong-
nam-do, n = 8), and Gangwon-do (n = 5); only one case was
reported from Jeollanam-do and no cases were reported from Jeju-
do (Figure 1). Cases ranged in age from 14 to 85 years (median
49.4 years), and by age group, 44.4% were aged 40–49 years, 26.7%
were aged 50–59 years, and 15.6% were aged 60 years (Table 1).
The distribution of cases across the age groups followed a similar
pattern for each of the study years; however the proportion of
cases in the 40–49 years age group was slightly lower in 2010
(38.5%) in comparison to 2007–2009 (42.9–66.7%). In 2007–2009,
71.4–100% of cases were male, whereas cases were more evenly
distributed between the sexes in 2010 (53.8% male).revention, South Korea, 2007–2010
Total
2009 2010
6 26 45
0.013 0.055 0.024
0 1 (3.8) 1 (2.2)
1 (16.6) 1 (3.8) 2 (4.4)
1 (16.6) 1 (3.8) 3 (6.7)
3 (50.0) 10 (38.5) 20 (44.4)
1 (16.6) 8 (30.8) 12 (26.7)
0 5 (19.2) 7 (15.6)
40.3 (21–56) 50.4 (14–77) 49.4 (14–85)
6 (100.0) 14 (53.8) 30 (66.7)
0 8 (30.8) 10 (22.2)
0 0 2 (4.4)
1 (16.7) 7 (26.9) 14 (31.1)
0 7 (26.9) 16 (35.6)
0 3 (11.5) 5 (11.1)
0 0 0
ometers of a pigsty or rice paddy.
imes a week.
 of the building.
re than 3 months before the onset of symptoms.
Figure 1. Distribution of 45 conﬁrmed cases of Japanese encephalitis reported in
South Korea. (There were no cases in Gwangju, Jeollabuk-do, and Jeju-do.).
Figure 2. Number of conﬁrmed Japanese encephalitis cases reported to the Korea
Centers for Disease Control and Prevention in 2007–2010, by epidemiological week.
(The ﬁrst epidemiological week is the ﬁrst week in January.).
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the years 2007–2010 (Figure 2). The earliest dates of symptom
onset were as follows: August 31 in 2007, August 22 in 2008,
September 23 in 2009, and August 6 in 2010. The latest dates of
symptom onset were as follows: November 1 in 2007, November 4
in 2008, October 22 in 2009, and October 15 in 2010. The
distribution of cases according to the date of symptom onset was
less deﬁned in 2007–2009, in comparison to 2010, in which a high
peak of activity was observed (Figure 2).
The epidemiological investigation revealed that 22.2% (10/45)
of conﬁrmed JE cases lived close to a pigsty and 4.4% (2/45) close to
a rice paddy (Table 1). Fourteen of the 45 cases (31.1%) were found
to have been involved in frequent nighttime outdoor activities.
These activities were as follows: ﬁve cases went on late-night
strolls, four cases returned from work late, three cases went night
ﬁshing, and two cases left for work at dawn. Sixteen of the 45 cases
(35.6%) were identiﬁed to have had outdoor occupations. These
occupations were as follows: four cases worked on a farm (yam,
rice), three cases worked at a factory with open space, two cases
worked as security guards (most time spent outside), and the
remaining cases worked as trafﬁc police, logistics manpower,
carpenter, construction manpower, ﬁsh farm manager, worker in
pigsty, and milkman. Two cases in 2008 and three cases in 2010
were found to be foreign-born immigrants. Their nationalities
were as follows: one from Canada, one from Nepal, and three from
China. All of these cases had resided in South Korea for at least
3 months. One case had a history of travel to Canada 3 weeks before
the onset of symptoms, but we considered this travel to beunrelated to the JE virus infection. Finally, none of 45 conﬁrmed
cases had a conﬁrmed history of vaccination against JE.
Most of the cases (88.9%) were seropositive for JE, with little
variation across the surveillance period, and 33.3% (15/45) of the
cases were positive in CSF PCR (Table 2). Among 19 cases with
an identiﬁed CSF proﬁle, the median CSF WBC count was
110  106 cells/l, while the median CSF protein and glucose
values were 74 mg/dl and 71 mg/dl, respectively. Of 45
conﬁrmed cases, 39 had ofﬁcial brain MRI ﬁndings presented
by radiologists. Among these, 21 (53.8%) were reported as JE, six
were reported as a nonspeciﬁc encephalitic infection, two were
reported as meningoencephalitis, and 10 were reported as
normal. From the review of the medical records, 13 cases were
identiﬁed to have had an underlying medical condition before
their illness: ﬁve cases of hypertension under medication, two
cases of chronic alcoholism, one ischemic stroke, one diabetes
mellitus, one case of ulcerative colitis, and three unknown
chronic medical conditions. Forty-three of the 45 cases (95.6%)
were admitted to the ICU, and there was one death attributable
to JE in 2007, none in 2008, two in 2009, and six in 2010,
resulting in an overall case fatality rate of 20.0% (9/45).
4. Discussion
Although JE has previously been recognized as a childhood
infection in South Korea, our ﬁndings show the highest incidence of
conﬁrmed JE in those aged 40–49 years. This ﬁnding provides
evidence of a shift in the age distribution of cases towards adults, as a
result of childhood cases being prevented by the vaccination
program.13 This is probably because this cohort was too old to
receive full vaccination when the mass vaccination program was
started in 1983. The age distributions of cases vary in different
countries. Before the introduction of vaccination programs, children
under 15 years were considered the high-risk group in China, India,
Thailand, and Sri Lanka, whereas all age groups were considered at
risk of JE infection in Burma and Nepal.14 In some countries like
Japan and Taiwan, where the wide utilization of vaccines and other
control measures have been performed, a modest shift in age
distribution towards adults has been observed, as we found in the
current study in South Korea.14,15 In our study, there was only one
case of JE in the age group encompassing children and adolescents –
a 14-year-old female junior high school student who had not
received the JE vaccine.
In South Korea, a mouse brain-derived inactivated vaccine
(Nakayama strain) has been used as one of the National Immuniza-
tion Program (NIP) vaccines, along with live attenuated SA 14-14-2
JE vaccine, which has been on the market since the late 1990s. Since
2000, public health centers have provided a three-dose primary
series of inactivated JE vaccine starting at 12 months of age, with two
booster doses at 6 years and 12 years, as recommended by the
Korean NIP. In the private health sector, inactivated JE vaccines are
competing with live attenuated JE vaccine; these are given as a two-
dose primary series starting at 12 months, with one booster dose at 6
years of age. The vaccination coverage rate was over 90% in 1985, but
a recent study has estimated lower nationwide coverage with the JE
vaccine – 80.9% for the ﬁrst/second doses and 53.0% for the third
dose.16 The current Korean NIP guidelines for JE vaccination
recommend vaccination only for children aged less than 12 years,
and do not yet provide any recommendations for the adult and
elderly populations.
In our study we found no change in the annual incidence of JE
during 2007–2009, but in 2010 a small spike occurred, with 26
conﬁrmed JE cases. The reason for this increase in 2010 is
uncertain; careful monitoring of trends in the following years will
be necessary. Although not included in the data of this study,
results from the epidemic forecast program conducted by the
Table 2
Clinical ﬁndings in Japanese encephalitis cases reported to the Korea Centers for Disease Control and Prevention, South Korea, 2007–2010
Year of surveillance Total
2007 2008 2009 2010
Conﬁrmed cases 7 6 6 26 45
Laboratory ﬁndings
Serum IgM positive, n (%) 7 (100.0) 5 (83.3) 6 (100.0) 22 (84.6) 40 (88.9)
CSF PCR positive, n (%) 0 2 (33.3) 2 (33.3) 11 (42.3) 15 (33.3)
Median CSF WBCa (cells  106/l) 101 284 210 69 110
Median CSF proteina (mg/dl) 125 87 80.5 63 74
Median CSF glucosea (mg/dl) 75 65 77 80 71
MRI report,b n (%)
JE or other encephalitis 5 (83.3) 5 (100.0) 2 (100.0) 17 (65.4) 29 (74.4)
Normal ﬁnding 1 (16.7) 0 0 9 (34.6) 10 (25.6)
Underlying diseases,c n (%) 1 (14.3) 1 (16.7) 1 (16.7) 10 (38.5) 13 (28.9)
ICU admission, n (%) 7 (100.0) 6 (100.0) 6 (100.0) 24 (92.3) 43 (95.6)
Deaths,d n (%) 1 (14.3) 0 2 (33.3) 6 (23.1) 9 (20.0)
CSF, cerebrospinal ﬂuid; PCR, polymerase chain reaction; WBC, white blood cell; MRI, magnetic resonance imaging; JE, Japanese encephalitis; ICU, intensive care unit.
a Data for four patients in 2007, four in 2008, two in 2009, and nine in 2010.
b Data for six patients in 2007, ﬁve in 2008, two in 2009, and 26 in 2010.
c Underlying diseases included diabetes mellitus, hypertension, chronic alcoholism, history of cerebrovascular disease, and ulcerative colitis.
d Death within 3 months of symptom onset; these are deaths potentially associated with the Japanese encephalitis infection.
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vector mosquito, seropositivity levels among sentinel piglets, and
viral strains, across the surveillance years 2007–2010. More
importantly, the estimated incidence of JE was still low at
0.013–0.055 per 100 000 population during 2007–2010, compared
to 0.1–1.8 per 100 000 population during 1980–1984.7Our ﬁndings
suggest some potential factors associated with the risk of acquiring
JE in South Korea. Most importantly, a vaccination history was
absent in all 45 conﬁrmed JE cases, including ﬁve foreign-born
residents from Canada, Nepal, and China. Although JE is endemic in
Nepal and China, and Canada offers travelers the vaccine, these
cases did not have a documented history of vaccination against
JE.17–19 The acquisition of JE was previously thought to be greatest
in rural areas, mostly in the southern part of the country, while our
data show that viral transmission existed within or at the
periphery of the urban areas of South Korea during 2007–2010;7
42.2% (19/45) of the cases were reported from urban or suburban
areas near Seoul, Incheon, and Gyeonggi-do, where more than 40%
of the population of South Korea resides.10 The relative frequency
of reported cases is notable because the population of vector
mosquitoes is not considered high in urban areas. This extends the
ﬁndings of other reports of sporadic cases from highly developed
areas such as Singapore, Hong Kong, and Taipei, where enzootic
transmission was thought to be absent.20–22
This study has several potential limitations. First, conﬁrmed JE
cases collected by the KCDC may not be representative of the
general South Korean population. Although mandated by law,
we do not know the estimated reporting rate of national notiﬁable
diseases in the country.11 Because of the limitations of a passive
reporting system, underestimation of the incidence is possible in
this study.
Secondly, due to the long-standing vaccination programs and
vector control in the country, acquiring more precise epidemio-
logical information has become necessary in order to assess factors
associated with JE infection in South Korea. In countries where
childhood cases are prevented by vaccination, further discussions
should be initiated for the selection of other high-risk groups for JE
vaccination, and the information regarding risk factors should be
procured in a more detailed manner. Moreover, because some
countries consider JE vaccines to be traveler’s vaccines for those
visiting South Korea, detailed information regarding risk factors
should be provided to address their vaccine strategies.23,24
Despite these limitations, we believe that our data may
represent the trend in countries with long-standing vaccinationpolicies that have resulted in a change in the patterns of
epidemiology of JE. Our observations may aid in establishing
baseline data for future discussions regarding vaccination strate-
gies in South Korea, and moreover may serve as a reference for
other countries when they are planning their vaccination policies
for travelers to endemic areas.
In conclusion, although JE has traditionally been regarded as a
children’s disease, the majority of cases now occur in adults in
countries where strong immunization programs exist, such as in
South Korea. Since the immunization program is targeted at
children under the age of 12 years and the natural booster effect
has been minimal due to vector control, seroprevalence research in
the adult population, followed by discussions on an adult
vaccination policy, should be considered in the near future.
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